Revelation Biosciences, Inc. (REVB) DCF Valuation

Revelation Biosciences, Inc. (REVB) DCF Valuation
  • ✓ Totalmente Editável: Adapte-Se Às Suas Necessidades No Excel Ou Planilhas
  • ✓ Design Profissional: Modelos Confiáveis ​​E Padrão Da Indústria
  • ✓ Pré-Construídos Para Uso Rápido E Eficiente
  • ✓ Não É Necessária Experiência; Fácil De Seguir

Revelation Biosciences, Inc. (REVB) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Designed for accuracy, our (REVB) DCF Calculator enables you to assess the valuation of Revelation Biosciences, Inc. using real-world financial data and offers complete flexibility to modify all essential parameters for improved projections.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Revenue Growth, % 0 0 0 0 0 0 0 0 0 0
EBITDA .0 -.1 -11.9 -10.8 -.1 .0 .0 .0 .0 .0
EBITDA, % 100 100 100 100 100 100 100 100 100 100
Depreciation .2 3.8 .1 .0 .0 .0 .0 .0 .0 .0
Depreciation, % 100 100 100 100 100 100 100 100 100 100
EBIT -.2 -3.9 -12.0 -10.9 -.1 .0 .0 .0 .0 .0
EBIT, % 100 100 100 100 100 100 100 100 100 100
Total Cash .0 4.5 1.3 5.3 12.0 .0 .0 .0 .0 .0
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables .0 .0 .0 .0 .0
Account Receivables, % 100 100 100 100 100
Inventories .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Inventories, % 100 100 100 100 100 100 100 100 100 100
Accounts Payable .0 .9 .6 .6 1.4 .0 .0 .0 .0 .0
Accounts Payable, % 100 100 100 100 100 100 100 100 100 100
Capital Expenditure .0 .0 -.1 .0 .0 .0 .0 .0 .0 .0
Capital Expenditure, % 100 100 100 100 100 0 0 0 0 0
Tax Rate, % 0 0 0 0 0 0 0 0 0 0
EBITAT -.2 -3.9 -12.0 -10.8 -.1 .0 .0 .0 .0 .0
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF .0 .7 -12.3 -10.8 .7 -1.4 .0 .0 .0 .0
WACC, % 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39 5.39
PV UFCF
SUM PV UFCF -1.3
Long Term Growth Rate, % 2.00
Free cash flow (T + 1) 0
Terminal Value 0
Present Terminal Value 0
Enterprise Value -1
Net Debt -12
Equity Value 11
Diluted Shares Outstanding, MM 0
Equity Value Per Share 46.80

What You Will Get

  • Real REVB Financial Data: Pre-filled with Revelation Biosciences’ historical and projected data for precise analysis.
  • Fully Editable Template: Modify key inputs like revenue growth, WACC, and EBITDA % with ease.
  • Automatic Calculations: See Revelation Biosciences’ intrinsic value update instantly based on your changes.
  • Professional Valuation Tool: Designed for investors, analysts, and consultants seeking accurate DCF results.
  • User-Friendly Design: Simple structure and clear instructions for all experience levels.

Key Features

  • Comprehensive Financial Data: Gain access to reliable historical data and future forecasts tailored for Revelation Biosciences, Inc. (REVB).
  • Adjustable Forecast Parameters: Modify highlighted cells such as WACC, growth rates, and profit margins to suit your analysis.
  • Real-Time Calculations: Enjoy automatic updates for DCF, Net Present Value (NPV), and cash flow assessments.
  • Interactive Dashboard: User-friendly charts and summaries to help you visualize the valuation outcomes effectively.
  • Designed for All Skill Levels: An intuitive layout catering to investors, CFOs, and consultants, whether seasoned or new.

How It Works

  1. Step 1: Download the Excel file for Revelation Biosciences, Inc. (REVB).
  2. Step 2: Review the pre-filled financial data and forecasts for REVB.
  3. Step 3: Adjust key inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Observe the DCF model update in real-time as you modify your assumptions.
  5. Step 5: Evaluate the outputs and leverage the results for your investment strategies.

Why Choose Revelation Biosciences, Inc. (REVB) Calculator?

  • Comprehensive Analysis: Offers in-depth evaluations including DCF, WACC, and essential financial ratios.
  • Flexible Parameters: Modify the highlighted cells to explore different financial scenarios.
  • In-Depth Analysis: Automatically computes the intrinsic value and Net Present Value for Revelation Biosciences.
  • Integrated Data: Access to historical and projected data for reliable analysis.
  • Expert-Level Tool: Perfect for financial analysts, investors, and business consultants focusing on biotechnology.

Who Should Use This Product?

  • Healthcare Investors: Develop comprehensive and accurate valuation models for biotechnology investments.
  • Corporate Development Teams: Evaluate valuation scenarios to shape strategic initiatives within the company.
  • Consultants and Advisors: Offer clients precise valuation insights for Revelation Biosciences, Inc. (REVB).
  • Students and Educators: Utilize real-world data to enhance learning and practice in financial modeling.
  • Biotech Enthusiasts: Gain insights into how biotech firms like Revelation Biosciences, Inc. (REVB) are assessed in the market.

What the Template Contains

  • Pre-Filled Data: Contains Revelation Biosciences, Inc.'s (REVB) historical financials and projections.
  • Discounted Cash Flow Model: Editable DCF valuation model with automatic calculations for REVB.
  • Weighted Average Cost of Capital (WACC): A dedicated sheet for calculating WACC based on tailored inputs.
  • Key Financial Ratios: Evaluate REVB's profitability, efficiency, and leverage metrics.
  • Customizable Inputs: Easily adjust revenue growth, profit margins, and tax rates.
  • Clear Dashboard: Visuals and tables summarizing essential valuation outcomes for REVB.

No products were found matching.